AMENDED AND RESTATED U.S. CO-PROMOTION AGREEMENTVeracyte, Inc. • November 13th, 2014 • Services-medical laboratories • New York
Genzyme Corporation, with offices located at 500 Kendall Street, Cambridge, Massachusetts 02142 (hereinafter referred to as “Genzyme”)
AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • November 13th, 2014 • Veracyte, Inc. • Services-medical laboratories • California
THIS AGREEMENT AND PLAN OF MERGER (the “Agreement”) is made and entered into as of September 4, 2014, by and among Veracyte, Inc., a Delaware corporation (“Parent”), Full Moon Acquisition, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), Allegro Diagnostics Corp., a Delaware corporation (the “Company”), Andrey Zarur, as the Stockholders’ Agent, and solely with respect to Section 2A below, Kodiak Venture Partners III, L.P., (“Kodiak Venture”), Kodiak III Entrepreneurs Fund, L.P. (“Kodiak”) and Catalyst Health Ventures L.P. (“Catalyst”) (Kodiak Venture, Kodiak and Catalyst are each a “Seller Party” and collectively, the “Seller Parties”). Capitalized terms used in this Agreement are defined and set forth on Exhibit A attached hereto and incorporated herein by reference.
